PURSUIT risk score

Revision as of 22:11, 11 February 2020 by Sabawoon Mirwais (talk | contribs)
Jump to navigation Jump to search

Definition and History

The PURSUIT (Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy) risk score was developed in a randomized clinical trial which recruited 9,461 patients and compared eptifibatide (Integrilin) to placebo in the management of Unstable Angina (UA) or Non-ST elevation Myocardial Infarction (NSTEMI).

Function